Tradestie Institutional Equity Comparison Engine
SRTM vs NIVF โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SRTM Overall Edge
SRTM Captures Institutional Edge (2โ1 Pillars ยท 2โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SRTM (SRTM) driven by superior Momentum & Technical, Options & Structure while NIVF counters with relative strength in Growth & Margin. Fundamentally, SRTM trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus NIVF at N/M Forward P/E and -238.2% operating margin (-4.7% YoY). In options structure, SRTM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NIVF sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SRTM N/M vs NIVF N/M Fwd P/E
Growth & Margin Winner
NIVF
Op Margin N/A vs -238.2% ยท YoY N/A vs -4.7%
Momentum & Technical Winner
SRTM
1Y -86.8% vs -91.8% ยท 52W Pos 2% vs 0%
Options & Structure Winner
SRTM
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
SRTM
US Equity
SRTM
Institutional Equity
$0.08
-14.59% 1D
Market Cap
N/A
1M Return
-80.4%
1Y Return
-86.83%
Forward P/E
N/M
Unified AI Score
47.6 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
NIVF
NASDAQ
NewGenIvf Group Limited Class A ordinary shares
Services-Misc Health & Allied Services, Nec
$0.03
-23.14% 1D
Market Cap
$98,000
1M Return
-81.93%
1Y Return
-91.82%
Forward P/E
N/M
Unified AI Score
47.7 / 100
HOLD
Tech 43.0
Fund 49.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SRTM -86.83%
NIVF -91.82%
Spread: +3.67 pp (SRTM Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SRTM TTM Op. Margin: N/A
NIVF TTM Op. Margin: -238.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SRTM vs NIVF. Trailing 12-month operating profitability (SRTM N/A vs NIVF -238.2%) and valuation multiples (SRTM N/M vs NIVF N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SRTM | NIVF | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $98,000 | Larger Scale | NIVF |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | -4.7% | Higher Growth | NIVF |
| Operating Margin (TTM) Profitability | N/A | -238.2% | Higher Margin | NIVF |
| Net Profit Margin Profitability | N/A | 24.2% | Higher Margin | NIVF |
| Return on Equity (ROE) Capital Efficiency | N/A | 5.5% | Higher ROE | NIVF |
| 52-Week Range Position Momentum | 2% ($0โ$1) | 0% ($0โ$3) | Stronger Trend | SRTM |
| Beta / 30D Volatility Risk Regime | N/A | 0.05ฮฒ ยท 3040% Vol | Lower Realized Risk | SRTM |
| Unified Institutional Score Composite Signal | 47.6 / 100 (HOLD) | 47.7 / 100 (HOLD) | Higher Composite | Tie |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SRTM vs NIVF Buy Guide
SRTM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
NIVF
BREAKDOWN
19d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SRTM nor NIVF registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.